ArticleBiomedicines2025

Prognostic Risk Model of Megakaryocyte-Erythroid Progenitor (MEP) Signature Based on AHSP and MYB in Acute Myeloid Leukemia.

Ting Bin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.